共 85 条
- [1] Jemal A(2011)Global cancer statistics CA Cancer J Clin. 61 69-90
- [2] Bray F(1997)Revisions in the international system for staging lung cancer Chest. 111 1710-1717
- [3] Center MM(2003)Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer J Natl Cancer Inst. 95 1453-1461
- [4] Ferlay J(2004)Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med. 350 351-360
- [5] Ward E(2004)Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial Eur J Cardiothorac Surg. 26 173-182
- [6] Forman D(2005)Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med. 352 2589-2597
- [7] Mountain CF(2006)Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol. 7 719-727
- [8] Scagliotti GV(2008)Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol. 26 3552-3559
- [9] Fossati R(2004)Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy J Clin Oncol. 22 1589-1597
- [10] Torri V(2008)Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer J Clin Oncol. 26 3543-3551